Neurology

VMAT2 inhibitors may offer effective symptom relief for pediatric hyperkinetic movement disorders, according to a new retrospective study reviewing over a decade of clinical use.

Breast cancer survivors may face a lower risk of Alzheimer’s disease than their cancer-free peers, according to a large retrospective cohort study examining long-term cognitive outcomes following treatment.

An emerging treatment model for migraine integrates behavioral and pharmacologic approaches via telehealth, potentially improving access and outcomes for patients with this highly disabling neurological condition.

Depression and anxiety, not motor decline, are the strongest predictors of quality of life in patients with progressive supranuclear palsy (PSP), according to a new study that underscores the pressing need for comprehensive symptom management beyond traditional motor assessments.

Clinical evaluation of small fiber neuropathy (SFN) remains inconsistent across neurology subspecialties, with survey data revealing wide variation in diagnostic practices, even when faced with common patient scenarios.

In a breakthrough that could accelerate research into Sudden Unexpected Death in Epilepsy (SUDEP), researchers have demonstrated that a state-of-the-art AI model, GPT-4o, can accurately extract neural projections from scientific literature.

Frailty is a critical predictor of mortality and neurological outcome in older patients undergoing endovascular therapy for ischemic stroke, according to a national German registry analysis involving over 2,400 patients.

Catatonia remains a misunderstood neuropsychiatric condition, and a new evidence-based review challenges ten prevailing myths that may delay diagnosis and compromise patient outcomes.

A new deep-learning framework using MRI scans offers promising accuracy in predicting brain age, cognitive decline, and amyloid plaque buildup, key factors in the early detection of Alzheimer’s disease and related neurodegenerative disorders.

Delirium remains a critical yet often underrecognized condition in acute care settings with direct links to increased mortality and extended hospital stays.

Vagus nerve stimulation (VNS) not only reduces seizures in patients with epilepsy but also leads to early and sustained improvements in mental health, sleep, and quality of life, according to a new multicenter cohort study.

Calcified cerebral emboli may significantly reduce the effectiveness of endovascular thrombectomy (EVT) and lead to worse outcomes in patients with acute ischemic stroke, according to new findings.

A new study examining vascular dementia (VaD) mortality in the United States from 2005 to 2020 reveals a marked rise in age-adjusted death rates, especially in specific regions and demographic groups.

In a breakthrough meta-analysis designed for clinicians and healthcare professionals, machine learning tools have shown promising accuracy in predicting hemorrhagic transformation (HT) in patients with acute ischemic stroke (AIS).

Healthcare professionals and neurologists across the U.S. are closely watching the emergence of ambient AI tools in clinical practice, especially as these technologies enter specialized settings like epilepsy care.

In a newly published systematic review of clinical trials, researchers evaluated the safety and efficacy of interventions aimed at promoting remyelination in multiple sclerosis (MS), a neurodegenerative disease characterized by inflammation, demyelination, and axonal damage in the central nervous system.

Late-onset migraine with aura in patients over 50 is gaining attention as a clinically distinct and underrecognized presentation, according to a new systematic review.

Public understanding of genetic testing for dementia remains limited and often misinformed, according to a new study analyzing Twitter conversations from 2010 to 2023.

In a major new prospective study examining ischemic stroke prognosis, researchers have found that patients with high-normal serum levels of potassium, calcium, and magnesium experienced significantly lower risks of death or major disability at 3 months.

Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) are common neurologic sleep-related conditions that affect millions of adults and children in the United States.

Excess weight is emerging as a significant risk factor for neurological and neuropsychiatric symptoms in post-COVID-19 condition (PCC), according to new findings presented in a new systematic review and meta-analysis.

Living near golf courses may significantly increase the risk of Parkinson’s disease, according to new research analyzing data from the Rochester Epidemiology Project.

Accurate tumor grading in glioma is essential for guiding treatment and predicting outcomes, yet current methods rely heavily on biopsy and histopathology.

In a new randomized controlled trial, daily anthocyanin supplementation significantly improved inflammation and cardiometabolic biomarkers in older adults at risk for dementia, a finding that may have implications for both brain and cardiovascular health.

In Parkinson’s disease (PD), gut microbiome imbalances and early symptoms like REM sleep behavior disorder (RBD) are increasingly recognized as clues to the condition’s origins and progression.

Parkinson’s disease (PD), a progressive neurodegenerative disorder impacting over 10 million people worldwide, is defined by the aggregation of misfolded α-synuclein (aSyn) in the substantia nigra pars compacta, leading to the hallmark motor symptoms of tremor, rigidity, and bradykinesia.

Persistent neuropsychiatric symptoms (NPS) in older adults could serve as early warning signs of underlying Alzheimer’s disease (AD) pathology, according to new research.

MRI continues to play a pivotal role in the early detection of Alzheimer’s disease, and new research suggests that using distance measures from MRI data may outperform traditional volumetric assessments in predicting cognitive decline.

Lewy body dementia (LBD), a complex neurodegenerative disorder, remains severely understudied in Latin America, according to a new scoping review analyzing the regional research landscape across major medical databases.

New research reveals that adults with rheumatoid arthritis (RA) are significantly more likely to develop sleep disorders, including insomnia, than those without the disease, a finding that raises important questions for rheumatologists and primary care providers.

In a comprehensive new study using National Health and Nutrition Examination Survey (NHANES) data from 1999 to 2020, researchers have identified strong links between specific lifestyle factors and the risk of stroke in U.S. adults.

In patients with branch atherosclerosis disease (BAD), early neurological deterioration (END) poses a significant threat to recovery, even in mild strokes.